UB Paderborn / Katalog / Suche / in CDI

1 – 24 von 24

Sortiert nach

Genomic and transcriptomic profiling expands precision cancer medicine: the WINTHER trial

Nature Medicine, 2019-05, Vol.25 (5), p.751-758

2019

Volltextzugriff (PDF)

The role of imatinib mesylate (Glivec) for treatment of patients with malignant endocrine tumors positive for c-kit or PDGF-R

Endocrine-related cancer, 2006-06, Vol.13 (2), p.535-540

2006

Volltextzugriff (PDF)

Combination Treatment of Intratumoral Vidutolimod, Radiosurgery, Nivolumab, and Ipilimumab for Microsatellite Stable Colorectal Carcinoma With Liver Metastases

Clinical colorectal cancer, 2023-12, Vol.22 (4), p.442-449.e1

2023

Volltextzugriff (PDF)

Nonmyeloablative allogeneic stem cell transplantation for the treatment of chronic myeloid leukemia in first chronic phase

Blood, 2003-01, Vol.101 (2), p.441-445

2003

Volltextzugriff (PDF)

Immunotherapy in high-risk chemotherapy-resistant patients with metastatic solid tumors and hematological malignancies using intentionally mismatched donor lymphocytes activated with rIL-2: a phase I study

Cancer Immunology, Immunotherapy, 2010-10, Vol.59 (10), p.1511-1519

2010

Volltextzugriff (PDF)

Allogeneic Cell Therapy With Donor Peripheral Blood Cells and Recombinant Human Interleukin-2 to Treat Leukemia Relapse After Allogeneic Bone Marrow Transplantation

Blood, 1996-03, Vol.87 (6), p.2195-2204

1996

Volltextzugriff (PDF)

Post-autologous stem cell transplantation administration of rituximab improves the outcome of patients with aggressive B cell non-Hodgkin's lymphoma

Annals of hematology, 2010-03, Vol.89 (3), p.263-272

2010

Volltextzugriff (PDF)

A randomized controlled multicenter study comparing recombinant interleukin 2 (rIL-2) in conjunction with recombinant interferon alpha (IFN-alpha) versus no immunotherapy for patients with malignant lymphoma postautologous stem cell transplantation

Journal of immunotherapy, 2010-04, Vol.33 (3), p.326-333

2010

Volltextzugriff (PDF)

Allogeneic stem cell transplantation for severe acquired aplastic anaemia using a fludarabine‐based preparative regimen

British journal of haematology, 2006-06, Vol.133 (6), p.649-654

2006

Volltextzugriff (PDF)

Complete remission of multiple myeloma after autoimmune hemolytic anemia: Possible association with interferon‐α

American journal of hematology, 2007-06, Vol.82 (6), p.489-492

2007

Volltextzugriff (PDF)

Successful transplantation of haploidentically mismatched peripheral blood stem cells using CD133 +-purified stem cells

Experimental hematology, 2005-06, Vol.33 (6), p.713-718

2005

Volltextzugriff (PDF)

A non-myeloablative conditioning regimen in allogeneic stem cell transplantation from related and unrelated donors in elderly patients

Haematologica (Roma), 2006-06, Vol.91 (6), p.852-855

2006

Volltextzugriff (PDF)

Adoptive immunotherapy with haploidentical allogeneic peripheral blood lymphocytes following autologous bone marrow transplantation

Experimental hematology, 2000-11, Vol.28 (11), p.1225-1231

2000

Volltextzugriff (PDF)

Successful engraftment following allogeneic stem cell transplantation in very high-risk patients with busulfan as a single agent

Haematologica (Roma), 2005-08, Vol.90 (8), p.1089

2005

Volltextzugriff (PDF)

Allogeneic cell-mediated immunotherapy for eradication of minimal residual disease: Comparison of T-cell and IL-2 activated killer (LAK) cell–mediated adoptive immunotherapy in murine models

Experimental hematology, 1999-03, Vol.27 (3), p.461-469

1999

Volltextzugriff (PDF)

Allogeneic Cell Therapy: The Treatment of Choice for All Hematologic Malignancies Relapsing Post BMT

Blood, 1996-05, Vol.87 (9), p.4011-4012

1996

Volltextzugriff (PDF)

Amplification of immunological functions by subcutaneous injection of intermediate-high dose interleukin-2 for 2 years after autologous stem cell transplantation in children with stage IV neuroblastoma

Transplantation, 2000-10, Vol.70 (7), p.1100

2000

Volltextzugriff (PDF)

Allogeneic cell-mediated and cytokine-activated immunotherapy for malignant lymphoma at the stage of minimal residual disease after autologous stem cell transplantation

Journal of immunotherapy, 1998-11, Vol.21 (6), p.447-453

1998

Volltextzugriff (PDF)

Role of interleukin-2 in human hematological malignancies

Medical oncology (Northwood, London, England), 1995-09, Vol.12 (3), p.177-186

1995

Volltextzugriff (PDF)

Immunotherapy of Minimal Residual Disease by Immunocompetent Lymphocytes and Their Activation by Cytokines

Cancer investigation, 1992, Vol.10 (3), p.221-227

1992

Volltextzugriff (PDF)

Allogeneic cell-mediated immunotherapy for breast cancer after autologous stem cell transplantation: a clinical pilot study

Cytokines, cellular & molecular therapy., 1998-03, Vol.4 (1), p.1

1998

Volltextzugriff (PDF)

Nonmyeloablative Stem Cell Transplantation and Cell Therapy as an Alternative to Conventional Bone Marrow Transplantation With Lethal Cytoreduction for the Treatment of Malignant and Nonmalignant Hematologic Diseases

Blood, 1998-02, Vol.91 (3), p.756-763

1998

Volltextzugriff (PDF)

Activated long-term peripheral blood cultures as preparation for adoptive alloreactive cell therapy in cancer patients

Journal of hematotherapy, 1997-04, Vol.6 (2), p.115-124

1997

Volltextzugriff (PDF)

Control of relapse due to minimal residual disease (MRD) by cell-mediated cytokine-activated immunotherapy in conjunction with bone marrow transplantation

Baillière's clinical haematology, 1991-07, Vol.4 (3), p.715-725

1991

Volltextzugriff (PDF)

1 – 24 von 24

Suche als RSS-Feed

Aktive Filter

KollektionMEDLINE

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(22)
Mit Volltextzugriff
(22)

Publikationsform

Artikel
(24)

Sprache

Englisch
(24)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

Humans
(22)
Life Sciences & Biomedicine
(21)
Science & Technology
(21)
Male
(18)
Female
(17)
Middle Aged
(16)
Adult
(15)
Biological And Medical Sciences
(12)
Medical Sciences
(12)
Adolescent
(11)
Hematology
(11)
Immunotherapy
(11)
Aged
(8)
Medicine, Research & Experimental
(8)
Oncology
(8)
Research & Experimental Medicine
(8)
Child
(7)
Hematologic And Hematopoietic Diseases
(7)
Treatment Outcome
(7)
Bone Marrow Transplantation
(6)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Genomic and transcriptomic profiling expands precision cancer medicine: the WINTHER trial

The role of imatinib mesylate (Glivec) for treatment of patients with malignant endocrine tumors positive for c-kit or PDGF-R

Combination Treatment of Intratumoral Vidutolimod, Radiosurgery, Nivolumab, and Ipilimumab for Microsatellite Stable Colorectal Carcinoma With Liver Metastases

Nonmyeloablative allogeneic stem cell transplantation for the treatment of chronic myeloid leukemia in first chronic phase

Immunotherapy in high-risk chemotherapy-resistant patients with metastatic solid tumors and hematological malignancies using intentionally mismatched donor lymphocytes activated with rIL-2: a phase I study

Allogeneic Cell Therapy With Donor Peripheral Blood Cells and Recombinant Human Interleukin-2 to Treat Leukemia Relapse After Allogeneic Bone Marrow Transplantation

Post-autologous stem cell transplantation administration of rituximab improves the outcome of patients with aggressive B cell non-Hodgkin's lymphoma

A randomized controlled multicenter study comparing recombinant interleukin 2 (rIL-2) in conjunction with recombinant interferon alpha (IFN-alpha) versus no immunotherapy for patients with malignant lymphoma postautologous stem cell transplantation

Allogeneic stem cell transplantation for severe acquired aplastic anaemia using a fludarabine‐based preparative regimen

Complete remission of multiple myeloma after autoimmune hemolytic anemia: Possible association with interferon‐α

Successful transplantation of haploidentically mismatched peripheral blood stem cells using CD133 +-purified stem cells

A non-myeloablative conditioning regimen in allogeneic stem cell transplantation from related and unrelated donors in elderly patients

Adoptive immunotherapy with haploidentical allogeneic peripheral blood lymphocytes following autologous bone marrow transplantation

Successful engraftment following allogeneic stem cell transplantation in very high-risk patients with busulfan as a single agent

Allogeneic cell-mediated immunotherapy for eradication of minimal residual disease: Comparison of T-cell and IL-2 activated killer (LAK) cell–mediated adoptive immunotherapy in murine models

Allogeneic Cell Therapy: The Treatment of Choice for All Hematologic Malignancies Relapsing Post BMT

Amplification of immunological functions by subcutaneous injection of intermediate-high dose interleukin-2 for 2 years after autologous stem cell transplantation in children with stage IV neuroblastoma

Allogeneic cell-mediated and cytokine-activated immunotherapy for malignant lymphoma at the stage of minimal residual disease after autologous stem cell transplantation

Role of interleukin-2 in human hematological malignancies

Immunotherapy of Minimal Residual Disease by Immunocompetent Lymphocytes and Their Activation by Cytokines

Allogeneic cell-mediated immunotherapy for breast cancer after autologous stem cell transplantation: a clinical pilot study

Nonmyeloablative Stem Cell Transplantation and Cell Therapy as an Alternative to Conventional Bone Marrow Transplantation With Lethal Cytoreduction for the Treatment of Malignant and Nonmalignant Hematologic Diseases

Activated long-term peripheral blood cultures as preparation for adoptive alloreactive cell therapy in cancer patients

Control of relapse due to minimal residual disease (MRD) by cell-mediated cytokine-activated immunotherapy in conjunction with bone marrow transplantation

Aktive Filter

Suchergebnisse filtern